UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linvencovir: Paving the way for functional cure in hepatitis B

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.164

2024

Volltextzugriff (PDF)

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Clinical and molecular hepatology, 2023, Vol.29 (1), p.113

2023

Volltextzugriff (PDF)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea

Clinical and molecular hepatology, 2021-10, Vol.27 (4), p.603

2021

Volltextzugriff (PDF)

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Clinical and molecular hepatology, 2023-07, Vol.29 (3), p.820

2023

Volltextzugriff (PDF)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B

Clinical and molecular hepatology, 2023, Vol.29 (1), p.146

2023

Volltextzugriff (PDF)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?

Clinical and molecular hepatology, 2023, Vol.29 (1), p.118

Young-suk Lim

2023

Volltextzugriff (PDF)

Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.276

2024

Volltextzugriff (PDF)

Congenital Hemophilia B, Rare Mutation c.368T>G, Presenting with Delayed Massive Expansion of Non-Traumatic Cephalhematoma

Perinatology (Online), 2024-06, Vol.35 (2), p.81

2024

Volltextzugriff (PDF)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Gut and liver, 2023-03, Vol.17 (2), p.280

2023

Volltextzugriff (PDF)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Gut and liver, 2023-03, Vol.17 (2), p.280

2023

Volltextzugriff (PDF)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Gut and liver, 2023-03, Vol.17 (2), p.280

2023

Volltextzugriff (PDF)

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Gut and liver, 2023-03, Vol.17 (2), p.280

2023

Volltextzugriff (PDF)

The role of different viral biomarkers on the management of chronic hepatitis B

Clinical and molecular hepatology, 2023, Vol.29 (2), p.263

2023

Volltextzugriff (PDF)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Gut and liver, 2023-03, Vol.17 (2), p.288

2023

Volltextzugriff (PDF)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Gut and liver, 2023-03, Vol.17 (2), p.288

2023

Volltextzugriff (PDF)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Gut and liver, 2023-03, Vol.17 (2), p.289

2023

Volltextzugriff (PDF)

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Gut and liver, 2023-03, Vol.17 (2), p.288

2023

Volltextzugriff (PDF)

Another oral antiviral treatment, but still far away from hepatitis B virus cure

Clinical and molecular hepatology, 2021-04, Vol.27 (2), p.281

Tai-chung Tseng

2021

Volltextzugriff (PDF)

Boeravinone B, a natural rotenoid, inhibits osteoclast differentiation through modulating NF-κB, MAPK and PI3K/Akt signaling pathways

BMB reports, 2023-10, Vol.56 (10), p.545-550

2023

Volltextzugriff (PDF)

Hereditary Fructose Intolerance Diagnosed in Adulthood

Gut and liver, 2021-01, Vol.15 (1), p.142

2021

Volltextzugriff (PDF)

Hereditary Fructose Intolerance Diagnosed in Adulthood

Gut and liver, 2021-01, Vol.15 (1), p.142

2021

Volltextzugriff (PDF)

Hereditary Fructose Intolerance Diagnosed in Adulthood

Gut and liver, 2021-01, Vol.15 (1), p.142

2021

Volltextzugriff (PDF)

Hereditary Fructose Intolerance Diagnosed in Adulthood

Gut and liver, 2021-01, Vol.15 (1), p.142

2021

Volltextzugriff (PDF)

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

Clinical and molecular hepatology, 2023, Vol.29 (2), p.367

2023

Volltextzugriff (PDF)

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase

Clinical and molecular hepatology, 2023, Vol.29 (2), p.482

2023

Volltextzugriff (PDF)

1 – 25 von 1.570

Suche als RSS-Feed

Aktive Filter

SpracheKoreanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.194)
Mit Volltextzugriff
(1.382)

Publikationsform

Artikel
(1.570)

Sprache

Englisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(246)
Hepatitis B
(198)
Hepatitis B Virus
(197)
Chronic Hepatitis B
(146)
Male
(141)
Female
(125)
Middle Aged
(116)
Adult
(109)
Nf-Κb
(105)
Chronic
(96)
Hepatitis B, Chronic - Drug Therapy
(75)
Aged
(72)
Antiviral Agents - Therapeutic Use
(70)
Hepatocellular Carcinoma
(66)
Entecavir
(53)
Liver Cirrhosis
(50)
Science & Technology
(49)
내과학
(49)
Hepatitis B Virus - Genetics
(48)
Life Sciences & Biomedicine
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Linvencovir: Paving the way for functional cure in hepatitis B

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?

Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research

Congenital Hemophilia B, Rare Mutation c.368T>G, Presenting with Delayed Massive Expansion of Non-Traumatic Cephalhematoma

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

Long-term Hepatitis B Surface Antigen Profile and Seroclearance after Severe Acute Flares of Chronic Hepatitis B

The role of different viral biomarkers on the management of chronic hepatitis B

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Another oral antiviral treatment, but still far away from hepatitis B virus cure

Boeravinone B, a natural rotenoid, inhibits osteoclast differentiation through modulating NF-κB, MAPK and PI3K/Akt signaling pathways

Hereditary Fructose Intolerance Diagnosed in Adulthood

Hereditary Fructose Intolerance Diagnosed in Adulthood

Hereditary Fructose Intolerance Diagnosed in Adulthood

Hereditary Fructose Intolerance Diagnosed in Adulthood

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase

Aktive Filter

Suchergebnisse filtern